NDC 0591-3551

Oxycodone and Aspirin

Oxycodone And Aspirin

Oxycodone and Aspirin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Oxycodone Hydrochloride; Aspirin.

Product ID0591-3551_0c3167ea-b863-485b-b18e-e7835803c9cb
NDC0591-3551
Product TypeHuman Prescription Drug
Proprietary NameOxycodone and Aspirin
Generic NameOxycodone And Aspirin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-10-18
Marketing End Date2020-06-30
Marketing CategoryANDA / ANDA
Application NumberANDA090084
Labeler NameActavis Pharma, Inc.
Substance NameOXYCODONE HYDROCHLORIDE; ASPIRIN
Active Ingredient Strength5 mg/1; mg/1
Pharm ClassesFull Opioid Agonists [MoA],Opioid Agonist [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
DEA ScheduleCII
NDC Exclude FlagN

Packaging

NDC 0591-3551-01

100 TABLET in 1 BOTTLE, PLASTIC (0591-3551-01)
Marketing Start Date2011-10-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-3551-01 [00591355101]

Oxycodone and Aspirin TABLET
Marketing CategoryANDA
Application NumberANDA090084
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-10-18
Marketing End Date2020-06-30

Drug Details

Active Ingredients

IngredientStrength
OXYCODONE HYDROCHLORIDE4.8355 mg/1

OpenFDA Data

SPL SET ID:a598f735-d2e2-43ad-be77-8627ea4a9b78
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 848768
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Full Opioid Agonists [MoA]
    • Opioid Agonist [EPC]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]

    NDC Crossover Matching brand name "Oxycodone and Aspirin" or generic name "Oxycodone And Aspirin"

    NDCBrand NameGeneric Name
    0591-3551Oxycodone and AspirinOxycodone and Aspirin
    68308-845Oxycodone and AspirinOxycodone Hydrochloride and Aspirin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.